SCHEMBL27667809

SCHEMBL27667809

CC(C)(C)OC(=O)NC1CCCC(CS(C)(=O)=O)C1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.58
KAT8 Q9H7Z6 5/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
EPHX1 P07099 1/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
GAA P10253 1/20 0.41
CTSK P43235 2/20 0.39
DRD2 P14416 2/20 0.38
KDM1A O60341 1/20 0.38
MAOB P27338 1/20 0.38
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
CYP2C9 P11712 1/20 0.36
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31512218 0.89 BTK (0.58) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL12424258 0.89 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL20689413 0.89 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL15284092 0.84 BTK (0.56) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL24448978 0.83 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL24449601 0.83 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL2377443 0.83 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL25319683 0.83 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL21027650 0.83 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1
SCHEMBL24448965 0.83 BTK (0.64) BTKKAT8KMT2AL3MBTL1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1871215-B Cyclic derivatives as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO 2011-06-08 CN disclosed
CN-1871215-A Cyclic derivatives as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO (US) 2006-11-29 CN disclosed